0000000000293856

AUTHOR

Kingshuk Roy Choudhury

showing 5 related works from this author

Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progressi…

2020

Purpose: To determine whether hepatobiliary phase hypointensity, enhancing “capsule” and size provide prognostic information regarding the risk of progression to hepatocellular carcinoma (HCC), as well as the time to progression, of intermediate to high risk observations ≥ 10 mm with arterial phase hyperenhancement (APHE). Method: This retrospective dual-institution study included 160 LR-3 and 26 LR-4 observations measuring more than 10 mm and having APHE in 136 patients (mean age [SD], 57 [11] years old). A composite reference standard of pathologic analysis and imaging follow-up was used. The prognostic performance of hepatobiliary phase hypointensity, enhancing “capsule” and size (cut-of…

Gadolinium DTPAMalemedicine.medical_specialtyGadoxetic acidCarcinoma HepatocellularContrast MediaIndependent predictorGastroenterologyTime030218 nuclear medicine & medical imagingCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineImage Interpretation Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imagingReference standardsRetrospective StudiesObserver Variationbusiness.industryTime to progressionLiver NeoplasmsMean ageGeneral MedicineMiddle AgedImage EnhancementPrognosismedicine.diseaseMagnetic Resonance ImagingLiverGadoxetic acid LI-RADS Hepatobiliary phase Hepatocellular carcinoma030220 oncology & carcinogenesisHepatocellular carcinomaDisease ProgressionHepatobiliary phaseFemalebusinessFollow-Up StudiesArterial phasemedicine.drug
researchProduct

Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.

2020

Background Hepatocellular adenomas (HCAs) are rare benign liver tumors. Guidelines recommend continued surveillance of patients diagnosed with HCAs, but these guidelines are mainly based on small studies or expert opinion. Purpose To analyze the long-term evolution of HCAs, including solitary and multiple lesions, and to identify predictive features of progression with MRI. Materials and Methods In a retrospective study, patients diagnosed with pathologically proven solitary or multiple HCAs between January 2004 and December 2015 were included; β-catenin-mutated HCAs and HCAs with foci of malignancy were considered to be at risk for progression. MRI examinations were analyzed, and tumor evo…

AdultMalePediatricsmedicine.medical_specialtyCarcinoma HepatocellularAdenomahepatocellular adenomaMEDLINEDiseaseliverMalignancyGastroenterology030218 nuclear medicine & medical imagingAdenoma Liver Cell03 medical and health sciencessymbols.namesakeText mining0302 clinical medicineMcNemar's testInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingFisher's exact testResponse Evaluation Criteria in Solid TumorsRetrospective Studiesbusiness.industryLiver NeoplasmsRetrospective cohort studymedicine.diseaseMagnetic Resonance ImagingTerm (time)Response Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesissymbolsDisease ProgressionFemalebusinessProgressive diseaseMRIFollow-Up StudiesRadiology
researchProduct

Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals.

2021

Background & Aims The risk of progression of indeterminate observations to hepatocellular carcinoma (HCC) after direct-acting antivirals (DAA) is still undetermined. To assess whether DAA therapy changes the risk of progression of observations with low (LR-2), intermediate (LR-3) and high (LR-4) probability for HCC in cirrhotic patients and to identify predictors of progression. Methods This retrospective study included cirrhotic patients treated with DAA who achieved sustained virological response between 2015 and 2019. A total of 68 patients had pre-DAA indeterminate observations and at least six months CT/MRI follow-up before and after DAA. Two radiologists reviewed CT/MRI studies to…

Liver Cirrhosismedicine.medical_specialtyMultivariate analysisCirrhosisCarcinoma HepatocellularGastroenterologyAntiviral Agents03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansRetrospective StudiesHepatologybusiness.industryProportional hazards modelHazard ratioLiver NeoplasmsRetrospective cohort studyHepatitis CHepatitis C Chronicmedicine.diseaseMagnetic Resonance Imaging030220 oncology & carcinogenesisHepatocellular carcinomaLI-RADS030211 gastroenterology & hepatologybusinessIndeterminateLiver international : official journal of the International Association for the Study of the LiverREFERENCES
researchProduct

Negative biopsy of focal hepatic lesions: Decision tree model for patient management

2019

OBJECTIVE. The purpose of this study was to investigate patient- and procedure-related variables affecting the false-negative rate of ultrasound (US)-guided liver biopsy and to develop a standardized patient-tailored predictive model for the management of negative biopsy results. MATERIALS AND METHODS. We retrospectively included 389 patients (mean age ± SD, 62 ± 12 years old) who had undergone US-guided liver biopsy of 405 liver lesions between January 1, 2013, and June 30, 2015. We collected multiple patient- and procedure-related variables. By comparing pathology reports of biopsy and the reference standard (further histology or imaging follow-up), we were able to categorize the biopsy r…

AdultImage-Guided BiopsyMalemedicine.medical_specialtyRadiology Nuclear Medicine and ImagingFalse Negative Result030218 nuclear medicine & medical imaging03 medical and health sciencesCore biopsyFalse-negative result0302 clinical medicineBiopsymedicineHumansFalse Negative ReactionsUltrasonography InterventionalAgedRetrospective StudiesAged 80 and overFine-needle aspirationmedicine.diagnostic_testUS-guided liver biopsybusiness.industryLiver DiseasesDecision TreesUltrasoundnutritional and metabolic diseasesGeneral MedicineMiddle AgedPatient managementDiagnostic errorFine-needle aspiration030220 oncology & carcinogenesisLiver biopsyFemaleRadiologybusinessCore biopsyDecision tree model
researchProduct

Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 1…

2020

This study was conducted in order to assess the diagnostic accuracy of LI-RADS v2018 ancillary features (AFs) favoring malignancy applied to LR-3 and LR-4 observations on gadoxetate-enhanced MRI. In this retrospective dual-institution study, we included consecutive patients at high risk for hepatocellular carcinoma (HCC) imaged with gadoxetate disodium-enhanced MRI between 2009 and 2014 fulfilling the following criteria: (i) at least one LR-3 or LR-4 observation ≥ 10 mm; (ii) nonrim arterial phase hyperenhancement; and (iii) confirmation of benignity or malignancy by pathology or imaging follow-up. We compared the distribution of AFs between HCCs and benign observations and the diagnostic p…

Gadolinium DTPAMalemedicine.medical_specialtyCirrhosisMultivariate analysisCarcinoma HepatocellularContrast MediaMalignancy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicineHumansRadiology Nuclear Medicine and imagingNeuroradiologyRetrospective Studiesmedicine.diagnostic_testbusiness.industryBenignityLiver NeoplasmsReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingHyperintensityResearch Design030220 oncology & carcinogenesisHepatocellular carcinomaFemaleRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCirrhosis Magnetic resonance imaging Hepatocellular carcinoma LiverEuropean radiology
researchProduct